Abstract:Probiotics are considered an alternative to antibiotics in the prevention and treatment of Salmonella diseases in poultry. However, to use probiotics as proposed above, it is necessary to evaluate their properties in detail and to select the most effective bacterial strains in the application targeted. In this study, probiotic properties of new Lactobacillus sp. strains were investigated and their antimicrobial activity against 125 environmental strains of Salmonella sp. was determined using the agar slab meth… Show more
“…These results indicate the gut microbiota modulation effect of AC5 on Salmonella infection in chickens. Although the anti-inflammatory effect of probiotic Limosilactobacillus on Salmonella in other experimental models has already been investigated (Abhisingha et al, 2018;Mohanty et al, 2019;Shi et al, 2019;Smialek et al, 2019;Acurcio et al, 2020;Kanmani and Kim, 2020;Kowalska et al, 2020;Mizuno et al, 2020), the strain-specific effect of the probiotic plays a crucial role in their different outcomes. Liu et al (2018) showed that prophylactic oral feeding with L. plantarum and L. rhamnosus reduced Salmonella numbers and improved gut barrier integrity in C57BL/6 mice.…”
Acute non-typhoidal salmonellosis (NTS) caused by Salmonella enterica Typhimurium (STM) is among the most prevalent of foodborne diseases. A global rising of antibiotic resistance strains of STM raises an urgent need for alternative methods to control this important pathogen. Major human food animals which harbor STM in their gut are cattle, swine, and poultry. Previous studies showed that the probiotic Limosilactobacillus (Lactobacillus) reuteri KUB-AC5 (AC5) exhibited anti-Salmonella activities in chicken by modulating gut microbiota and the immune response. However, the immunobiotic effect of AC5 in a mammalian host is still not known. Here, we investigated the anti-Salmonella and anti-inflammatory effects of AC5 on STM infection using a mouse colitis model. Three groups of C57BL/6 mice (prophylactic, therapeutic, and combined) were fed with 109 colony-forming units (cfu) AC5 daily for 7, 4, and 11 days, respectively. Then, the mice were challenged with STM compared to the untreated group. By using a specific primer pair, we found that AC5 can transiently colonize mouse gut (colon, cecum, and ileum). Interestingly, AC5 reduced STM gut proliferation and invasion together with attenuated gut inflammation and systemic dissemination in mice. The decreased STM numbers in mouse gut lumen, gut tissues, and spleen possibly came from longer AC5 feeding duration and/or the combinatorial (direct and indirect inhibitory) effect of AC5 on STM. However, AC5 attenuated inflammation (both in the gut and in the spleen) with no difference between these three approaches. This study demonstrated that AC5 confers both direct and indirect inhibitory effects on STM in the inflamed gut.
“…These results indicate the gut microbiota modulation effect of AC5 on Salmonella infection in chickens. Although the anti-inflammatory effect of probiotic Limosilactobacillus on Salmonella in other experimental models has already been investigated (Abhisingha et al, 2018;Mohanty et al, 2019;Shi et al, 2019;Smialek et al, 2019;Acurcio et al, 2020;Kanmani and Kim, 2020;Kowalska et al, 2020;Mizuno et al, 2020), the strain-specific effect of the probiotic plays a crucial role in their different outcomes. Liu et al (2018) showed that prophylactic oral feeding with L. plantarum and L. rhamnosus reduced Salmonella numbers and improved gut barrier integrity in C57BL/6 mice.…”
Acute non-typhoidal salmonellosis (NTS) caused by Salmonella enterica Typhimurium (STM) is among the most prevalent of foodborne diseases. A global rising of antibiotic resistance strains of STM raises an urgent need for alternative methods to control this important pathogen. Major human food animals which harbor STM in their gut are cattle, swine, and poultry. Previous studies showed that the probiotic Limosilactobacillus (Lactobacillus) reuteri KUB-AC5 (AC5) exhibited anti-Salmonella activities in chicken by modulating gut microbiota and the immune response. However, the immunobiotic effect of AC5 in a mammalian host is still not known. Here, we investigated the anti-Salmonella and anti-inflammatory effects of AC5 on STM infection using a mouse colitis model. Three groups of C57BL/6 mice (prophylactic, therapeutic, and combined) were fed with 109 colony-forming units (cfu) AC5 daily for 7, 4, and 11 days, respectively. Then, the mice were challenged with STM compared to the untreated group. By using a specific primer pair, we found that AC5 can transiently colonize mouse gut (colon, cecum, and ileum). Interestingly, AC5 reduced STM gut proliferation and invasion together with attenuated gut inflammation and systemic dissemination in mice. The decreased STM numbers in mouse gut lumen, gut tissues, and spleen possibly came from longer AC5 feeding duration and/or the combinatorial (direct and indirect inhibitory) effect of AC5 on STM. However, AC5 attenuated inflammation (both in the gut and in the spleen) with no difference between these three approaches. This study demonstrated that AC5 confers both direct and indirect inhibitory effects on STM in the inflamed gut.
“…enterica subspecies enterica ) is associated with the development of disease in warm-blooded animals. In the subspecies S. enterica , the serovars Enteritidis and Typhimurium are most prevalent both in humans and in poultry [ 55 , 56 ]. Salmonella enterica serovar Enteritidis is commonly associated with poultry and derived products, whereas serovar Typhimurium has a wider species range, affecting pigs and cattle as well as poultry [ 57 ].…”
Section: Salmonella
Spp Infectionmentioning
confidence: 99%
“…However, other mechanisms are also involved in probiotic effects such as reduction in intraluminal pH due to production of short chain fatty acids, production of antimicrobial peptides, optimization of intestinal functionality and activation of immune response. Researchers tested single or multi-strain probiotics, in particular Lactobacillus , Enterococcus , and Bacillus strains, with encouraging results after a Salmonella challenge in chickens, considering parameters such as bacterial count in ceca, faecal bacterial load, growth performance, and immune functionality [ 56 , 66 , 67 , 68 , 69 , 70 , 71 ]. The effect of commercially available probiotic supplements such as EarlyBird ® (Pacific Vet Group USA Inc., Fayetteville, AR, USA) and FloraMax-B11 ® (Pacific Vet Group USA Inc., Fayetteville, AR, USA) alone, or with the addition of glycerol, was tested to obtain a protective effect against Salmonella Enteritidis colonization, demonstrating the prevention of intestinal colonization from the pathogen [ 72 , 73 ].…”
In poultry, severe gastrointestinal diseases are caused by bacteria and coccidia, with important economic losses in the poultry industry and requirement of treatments which, for years, were based on the use of antibiotics and chemotherapies. Furthermore, Salmonella spp., Clostridium perfringens, and Campylobacter jejuni can cause serious foodborne diseases in people, resulting from consumption of poultry meat, eggs, and derived products. With the spread of antibiotic resistance, which affects both animals and humans, the restriction of antibiotic use in livestock production and the identification of a list of “critically important antimicrobials” became necessary. For this reason, researchers focused on natural compounds and effective alternatives to prevent gastrointestinal disease in poultry. This review summarizes the results of several studies published in the last decade, describing the use of different nutraceutical or phytonutrients in poultry industry. The results of the use of these products are not always encouraging. While some of the alternatives have proven to be very promising, further studies will be needed to verify the efficacy and practical applicability of other compounds.
“…dalam menanggulangi infeksi Salmonella sp. dibagi menjadi 3 cara yaitu memproduksi asam laktat dan short-chain fatty acid (SCFA), berperan sebagai imunomodulator saat berinteraksi dengan sistem kekebalan tubuh dan bertindak sebagai physical barrier dengan melakukan kolonisasi (Menconi et al, 2011;Chen et al, 2012;Filho et al, 2015;Olnood et al, 2015;Ashayerizadeh et al, 2016;Nakphaichit et al, 2018;Kowalska et al, 2020).…”
Ayam broiler harus dipastikan terhindar dari penyakit zoonosis, salah satunya Salmonellosis. Resistensi Salmonella sp. terhadap berbagai antibiotik menjadi salah satu alasan dalam penggunaan probiotik sebagai pilihan alternatif untuk mengatasi Salmonellosis. Lactobacillus sp. umum digunakan sebagai probiotik untuk menanggulangi Salmonellosis pada ayam broiler. Lactobacillus sp. dapat menerima agen resisten terhadap antibiotik, baik dari lingkungan maupun di saluran pencernaan ayam. Lactobacillus sp. dapat menjadi reservoir dalam penyebaran agen resisten antibiotik. Berdasarkan hasil studi literatur, Lactobacillus sp. mampu melakukan CE (competitive exclusion) sehingga dapat mengurangi populasi bakteri patogen. Lactobacillus sp. yang diambil dari biakan, saluran pencernaan, feses, daging serta sumber air di sekitar peternakan dan rumah potong unggas memiliki sifat resisten terhadap antibiotik vankomisin, kloramfenikol, tetrasiklin dan eritromisin. Lactobacillus sp. bertindak sebagai pendonor maupun penerima gen resisten terhadap antibiotik kloramfenikol, tetrasiklin dan eritromisin yang disebarkan secara horizontal melalui konjugasi plasmid dan transposon. Lactobacillus sp. yang teridentifikasi resisten terhadap antibiotik vankomisin memiliki potensi transfer gen resisten yang rendah dikarenakan sifat resisten terhadap vankomisin merupakan resistensi instrinsik sehingga secara tidak langsung sifat tersebut sangat kecil kemungkinannya dapat disebarkan secara horizontal kepada mikroorganisme lainnya.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.